✦ LIBER ✦

Successful switch to tenofovir after suboptimal response to entecavir in an immunocompromised patient with chronic hepatitis B and without genotypic hepatitis B virus resistance

✍ Scribed by C. Sarrecchia; V. Svicher; A. Volpi; R. Salpini; L. Ceccarelli; P. Sordillo; A. Bertoli; C. F. Perno; M. Andreoni

Book ID: 107705962
Publisher: Springer-Verlag
Year: 2011
Tongue: English
Weight: 223 KB
Volume: 39
Category: Article
ISSN: 0300-8126
DOI: 10.1007/s15010-011-0127-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Response to tenofovir monotherapy in chr

Response to tenofovir monotherapy in chronic hepatitis B patients with prior suboptimal response to entecavir

✍ C. Q. Pan; K.-Q. Hu; A. S. Yu; W. Chen; C. Bunchorntavakul; K. R. Reddy 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 133 KB

[504] SWITCHING LAMIVUDINE RESISTANT CHR

[504] SWITCHING LAMIVUDINE RESISTANT CHRONIC HEPATITIS B PATIENTS FROM TENOFOVIR TO ADEFOVIR RESULTS IN HBVDNA RELAPSE WITHOUT EVIDENCE OF GENOTYPIC RESISTANCE

✍ W.F. Leemans; H.L. Janssen; H.G. Niesters; S.W. Schalm; R.A. de Man 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 148 KB

P1064 RANDOMIZED TRIAL OF TENOFOVIR MONO

P1064 RANDOMIZED TRIAL OF TENOFOVIR MONOTHERAPY VERSUS TENOFOVIR PLUS ENTECAVIR COMBINATION THERAPY IN CHRONIC HEPATITIS B PATIENTS WITH GENOTYPIC RESISTANCE MUTATIONS TO ADEFOVIR

✍ Lim, Y.-S.; Yoo, B.C.; Byun, K.S.; Kwon, S.Y.; Kim, Y.J.; An, J.; Lee, H.C.; Lee 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 60 KB

Partial Response to Entecavir and Tenofo

Partial Response to Entecavir and Tenofovir in Naïve Patients with Chronic Hepatitis B: Clinical Relevance and Management

✍ Pietro Lampertico, Mauro Viganò, Massimo Colombo 📂 Article 📅 2012 🏛 Current Science Inc. 🌐 English ⚖ 123 KB

Switching patients with lamivudine resis

Switching patients with lamivudine resistant chronic hepatitis B virus from tenofovir to adefovir results in less potent HBV-DNA suppression

✍ W. F. Leemans; H. L. A. Janssen; H. G. M. Niesters; R. A. De Man 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 195 KB

No resistance to tenofovir disoproxil fu

No resistance to tenofovir disoproxil fumarate detected after up to 144 weeks of therapy in patients monoinfected with chronic hepatitis B virus

✍ Andrea Snow-Lampart; Brandi Chappell; Maria Curtis; Yuao Zhu; Florence Myrick; J 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 582 KB

Tenofovir disoproxil fumarate (TDF) is a nucleotide analogue with potent activity against human immunodeficiency virus type 1 and hepatitis B virus (HBV). To date, no reports of HBV clinical resistance to TDF have been confirmed. In two phase 3 studies (GS-US-174-0102 and GS-US-174-0103), 375 hepati